T

op of the morning to you, and a fine one, especially so here at the temporary Pharmalot campus, where the substitute mascot has ceased yapping and we are left to focus on the tasks at hand. And there are many tasks — meetings, deadlines, phone calls, and things to read. Oh, my. This calls for a cup or three of stimulation and, as always, you are invited to join us. Meanwhile, here is the menu of tidbits to help you get started on your own day. We hope all goes well and do drop us a line if you run across anything interesting. We accept encrypted messages and dossiers …

An Indian court upheld a $550 million award granted to Daiichi Sankyo against the former owners of Ranbaxy Laboratories, who concealed information about fraudulent practices and ongoing investigations during talks that led to a $4.6 billion sale of the generic drug maker in 2008, The Economic Times reports. Daiichi took Malvinder Singh and Shivinder Singh to a tribunal in 2013 after pleading guilty to felony charges because Ranbaxy distributed adulterated medicines in the U.S. and falsified data. Daiichi paid a $500 million settlement with the U.S. Department of Justice.

Unlock this article by subscribing to STAT Plus today. Try it FREE for 30 days and cancel anytime!

SUBSCRIBE TODAY

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.